Cummings Keith Lamont 4
4 · PLIANT THERAPEUTICS, INC. · Filed Jan 24, 2024
Insider Transaction Report
Form 4
Cummings Keith Lamont
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-23+110,500→ 110,500 totalExercise: $17.44Exp: 2034-01-23→ Common Stock (110,500 underlying) - Award
Common Stock
2024-01-23+55,250→ 249,855 total
Footnotes (2)
- [F1]These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.
- [F2]1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date.